All In Biotech

Drug Trial Radar · NCT06558188

Combined Anabolic Therapy

Combined Anabolic Therapy Study

Last checked: Nov 20, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

50

Planned (sponsor's estimate)

Start

Feb 3, 2025

Primary completion

Nov 2, 2027

Study completion Nov 19, 2027

Sponsor

Lead sponsor
Massachusetts General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
First posted
Aug 16, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

In this research study the study investigators want to learn more about the effect of two different FDA-approved medication regimens in the treatment of postmenopausal osteoporosis.

Conditions

  • Osteoporosis, Postmenopausal
  • Osteoporosis

Interventions

  • RomosozumabDrug

    romosozumab 210 milligrams monthly

  • TeriparatideDrug

    teriparatide 20 micrograms daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lumbar spine areal bone mineral densityTime frame: Month 0 to 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Massachusetts General Hospital

    Boston, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.